Holen Sie sich die Stockscreener-App
32.00
1.65%
-0.50
Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten
[EFFECT] Cue Biopharma, Inc. SEC Filing - Stock Titan
CUE Stock Jumps Over 100% After Hours — What’s Driving The Rally? - Stocktwits
Signal Law Group Issues VRS Bulletin on Cue Biopharma, Inc. (CUE) - The Daily Tribune News
Cue Biopharma, Inc.(NasdaqCM: CUE) added to Russell 3000E Growth Benchmark - marketscreener.com
Cue Biopharma, Inc.(NasdaqCM: CUE) added to Russell 3000E Index - marketscreener.com
Cue Biopharma, Inc.(NasdaqCM: CUE) added to Russell Microcap Index - marketscreener.com
CUE Stock On Track For Best Day In History — Why Is Retail Optimistic? - Stocktwits
Price to book forward of Cue Biopharma, Inc. – NASDAQ:CUE - TradingView
Price to book forward of Cue Biopharma, Inc. – LS:A426PN - TradingView
Cue Biopharma(CUE) Stock Options Chain | Quotes & News - Moomoo
Enterprise value to EBITDA forward of Cue Biopharma, Inc. – LS:A426PN - TradingView
Enterprise value to revenue forward of Cue Biopharma, Inc. – LS:A426PN - TradingView
Cue Biopharma Company Profile & Introduction - Moomoo
Price to earnings forward of Cue Biopharma, Inc. – LS:A426PN - TradingView
Price to sales forward of Cue Biopharma, Inc. – LS:A426PN - TradingView
Long term debt to total equity ratio of Cue Biopharma, Inc. – LS:A426PN - TradingView
Cue Biopharma Inc (CUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lin Shao-Lee - Moomoo
Cue Biopharma Stocklong-term strategy in immuno-oncology - AD HOC NEWS
Cue Biopharma Inc (CUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
CUE BIOPHARMA INC (CUE) Stock Chart - ChartMill
Cue Biopharma (NASDAQ: CUE) registers 551,724 pre-funded-warrant shares for resale - Stock Titan
Cue Biopharma Inc (CUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cue Biopharma | EFFECT: Others - Moomoo
Cue Biopharma Inc (CUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cue Biopharma Inc (CUE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cue Biopharma Inc (CUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cue Biopharma Inc (CUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cue Biopharma Inc (CUE) Institutional Confidence - TradingKey
Cue Biopharma Inc (CUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cue Biopharma Inc Stock (US22966J1060): Analyst focus after sharp move and oncology pipeline updates - Ad-hoc-news.de
CUE Q3 2025 Earnings: Narrower-Than-Expected Loss Highlights Progress in Pre-Revenue StageProfit Announcement - lwvtexas.org
Cue Biopharma (CUE) VP and Principal Accounting Officer files initial Form 3 - Stock Titan
Ray Sumita reports Cue Biopharma (CUE) shares and 109,179-share option - Stock Titan
Breakeven Is Near for Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) - simplywall.st
Cue Biopharma | 3: Initial statement of beneficial ownership of securities- Meluzio Michael Vincent - Moomoo
Breakeven On The Horizon For NanoXplore Inc. (TSE:GRA) - simplywall.st
Cue Biopharma: Viola Meehan Joins the Bd >CUE - Moomoo
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Cue Biopharma (CUE) director awarded 1,626 stock options at $21.90 strike - Stock Titan
Daniel A. Camardo joins Cue Biopharma (CUE) board and files Form 3 - Stock Titan
Cue Biopharma, Inc. - MLQ.ai
Cue Biopharma | 3: Initial statement of beneficial ownership of securities- Camardo Daniel A. - Moomoo
CUE stock slips as CEO leaves after just six months in role - MSN
Cue Biopharma (CUE) Narrows Slightly as Stock Holds Near Key Support LevelsMoney Flow Index - newsline.com
Cue Biopharma: Jill Broadfoot, Peter Kiener, Frank Morich and Patrick Verheyen Have Resigned From the Bd >CUE - Moomoo
Cue Biopharma Inc stock (US22966J1060): Nasdaq-listed immunotherapy developer after reverse split an - AD HOC NEWS
Veru And 2 Other Intriguing Penny Stocks To Watch - simplywall.st
Cue Biopharma Shareholders Approve 2026 Stock Incentive Plan - The Globe and Mail
[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan
Cue Biopharma (NASDAQ: CUE) investors approve warrant share issuance and 2026 stock incentive plan - Stock Titan
4.09M-share resale registration from CUE private placement (NASDAQ: CUE) - Stock Titan
Cue Biopharma Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Cue Biopharma, Inc. 8-K SEC Filing Details: Company Information, Exchange, and Security Data (May 29, 2026) - Minichart
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution - The Manila Times
Cue Biopharma, Inc. (CUE) Latest Stock News & Headlines - Yahoo Finance
1.16%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):